BridgeMD
New treatment option for Opioid Use
Official title The Effect of Preoperative Maxigesic® on Intraoperative Remifentanil Requirement
ClinicalTrials.gov ID: NCT06015711
What this study is testing
What is Maxigesic administration?
Maxigesic administration is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for opioid use.
Also referred to as Preoperative Maxigesic administration.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Maxigesic is combined intravenous analgesic of ibuprofen and acetaminphen. The purpose of this study is investigate weather preoperative Maxigesic administration can reduce intraoperative remifentanil requirement.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 to 60
You may be able to join if
- Adult patients (19-60 years old) with ASA physical status 1, 2, 3
- Scheduled surgery under general anesthesia
You likely can't join if
- The patient does not conset
- Pregnancy
- hepatic disorder
- Renal disorder
- Asthma
- Hypersensitivity to the NSAIDs or acetaminophen
See the full eligibility criteria
- Adult patients (19-60 years old) with ASA physical status 1, 2, 3
- Scheduled surgery under general anesthesia
- The patient does not conset
- Pregnancy
- hepatic disorder
- Renal disorder
- Asthma
- Hypersensitivity to the NSAIDs or acetaminophen
- Patients receiving chronic pain therapy
- Drug dependence
- Patients taking psychiatric drugs
- Alcoholics
- History of gastrointestinal ulcer or bleeding
The study team makes the final eligibility decision.
Where it's taking place
- Suwon, Gyeonggi-do, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Suwon, Gyeonggi-do, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.